Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

Board Committees

Audit Committee Position

Robert E. George

Director

Chair

Michael D. Cannon

Director

Member

Audit Committee Committee Charter

Download
Compensation Committee Position

Robert E. George

Director

Member

Michael D. Cannon

Director

Member

Compensation Committee Committee Charter

Download
Nominating and Corporate Governance Committee Position

Robert E. George

Director

Chair

Michael D. Cannon

Director

Member

Nominating and Corporate Governance Committee Committee Charter

Download